|
WO2021025135A1
|
|
Drug solution container and infusion bag
|
|
JP2020146525A
|
|
Multi-chamber container and production method thereof
|
|
WO2020218461A1
|
|
Trehalose-containing liquid for mammalian cell preservation
|
|
JP2020108824A
|
|
Multi-chamber container
|
|
WO2020196381A1
|
|
Infusion for subcutaneous administration
|
|
TW202045121A
|
|
Mixing and injecting tool, and mixing and injecting container provided with same
|
|
WO2020066991A1
|
|
Mammal cell preserving solution containing acarbose or stachyose
|
|
AU2019307996A1
|
|
Disinfectant composition
|
|
JP2021001144A
|
|
Nutritive composition
|
|
TW202011972A
|
|
Topical composition
|
|
JP2020172277A
|
|
Self-standing container and manufacturing method thereof
|
|
JP2019069156A
|
|
Multi-chamber container and method for manufacturing the same
|
|
JP2020074932A
|
|
Mixture injection tool and medicine container comprising the same
|
|
JP2020074933A
|
|
Double hook needle
|
|
EP3701976A1
|
|
Adhesion prevention material
|
|
WO2020065769A1
|
|
Ethylene-based resin composition
|
|
EP3680324A1
|
|
Stem cells derived from young pig and preparation method therefor
|
|
US2020055821A1
|
|
Method for manufacturing diastereomer of citric acid derivative
|
|
EP3628314A1
|
|
Anti-inflammatory agent
|
|
JP2019182473A
|
|
Package
|
